What are the symptoms of hypercalcemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hypercalcemia typically presents with symptoms such as polyuria, polydipsia, nausea, confusion, vomiting, abdominal pain, and myalgia, which can progress to severe dehydration, acute renal failure, and mental status changes if left untreated. The clinical symptoms of hypercalcemia depend on the severity and acuity of onset, with mild or moderate hypercalcemia often causing symptoms like polyuria, polydipsia, nausea, confusion, vomiting, abdominal pain, and myalgia 1.

Common Symptoms

  • Polyuria
  • Polydipsia
  • Nausea
  • Confusion
  • Vomiting
  • Abdominal pain
  • Myalgia

When hypercalcemia is severe (> 14.0 mg/dL), patients may develop mental status changes, bradycardia, and hypotension 1. The diagnostic evaluation includes measuring serum concentrations of intact parathyroid hormone (iPTH), parathyroid hormone-related protein (PTHrP), 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, calcium, albumin, magnesium, and phosphorus.

Management

The management of hypercalcemia includes oral hydration for mild cases, and rehydrating with IV crystalloid fluids not containing calcium, giving loop diuretics (eg, furosemide) as needed after correction of intravascular volume, and using bisphosphonates (clodronate, pamidronate, and zoledronic acid) for moderate to severe hypercalcemia 1. Additional therapeutic options such as glucocorticoids, gallium nitrate, and salmon calcitonin may be considered 1.

Prompt medical attention is necessary, especially when calcium levels exceed 14 mg/dL, as this constitutes a medical emergency that can lead to cardiac arrest and death if left untreated. The median survival after discovery of hypercalcemia of malignancy in patients with lung cancer is about 1 month 1, highlighting the importance of early diagnosis and treatment.

From the Research

Symptoms of Hypercalcemia

The symptoms of hypercalcemia can vary depending on the severity of the condition.

  • Mild hypercalcemia is usually asymptomatic, but may be associated with constitutional symptoms such as fatigue and constipation in approximately 20% of people 2.
  • Severe hypercalcemia can cause nausea, vomiting, dehydration, confusion, somnolence, and coma 2, 3.
  • Hypercalcemia can also cause bone pain, kidney stones, and abdominal cramps 3.

Causes of Hypercalcemia

Hypercalcemia can be caused by a variety of factors, including:

  • Primary hyperparathyroidism (PHPT) or malignancy, which account for approximately 90% of cases 2.
  • Granulomatous disease, such as sarcoidosis, and endocrinopathies, such as thyroid disease 2.
  • Immobilization, genetic disorders, and medications, such as thiazide diuretics and supplements, such as calcium, vitamin D, or vitamin A 2.
  • Sodium-glucose cotransporter 2 protein inhibitors, immune checkpoint inhibitors, denosumab discontinuation, SARS-CoV-2, ketogenic diets, and extreme exercise, although these account for less than 1% of causes 2.

Treatment of Hypercalcemia

The treatment of hypercalcemia depends on the underlying cause and severity of the condition.

  • Mild hypercalcemia usually does not require acute intervention, but may be managed with observation and monitoring 2.
  • Severe hypercalcemia is typically treated with hydration and intravenous bisphosphonates, such as zoledronic acid or pamidronate 2, 3.
  • Glucocorticoids may be used as primary treatment when hypercalcemia is due to excessive intestinal calcium absorption (vitamin D intoxication, granulomatous disorders, some lymphomas) 2, 4.
  • Bisphosphonates, such as pamidronate and zoledronic acid, are effective in reducing serum calcium levels and improving symptoms, but may be associated with an increased risk of serum creatinine elevations in patients with preexisting renal dysfunction 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypercalcemia: A Review.

JAMA, 2022

Research

Treatment of hypercalcemia.

Endocrinology and metabolism clinics of North America, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.